ILMN: Prakiraan rega marang bathi Illumina

ILMN (Illumina, Inc.) - tandha merek perusahaan

Illumina, Inc. (ILMN) maintains its leadership in genomics by leveraging affordable sequencing to lock customers into expensive reagents. The company's forward P/E ratio visualizes this strategy, where 33.50 shapes the current metric. Growth will be driven by NovaSeq X and optimization following the divestiture of Grail. Patent protection for NGS systems and a massive installed base guarantee a steady stream of profit from consumables.

Kapitalisasi marang proyeksi bathi: illumina.com (ILMN) kanggo 04.07.2022 - 16.11.2026

Rincian analitis lan laporan data perusahaan Illumina, Inc. (ILMN)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:ILMN Illumina Corp
Produk mawa merek Illumina Platform

The "razor-and-blade" model of Illumina, Inc. (ILMN) ensures a stable cash flow through the sale of consumables for installed sequencers. By analyzing the company's forward P/E ratio on GURU.Markets, an investor assesses the asset's market value relative to future earnings. This metric is calculated as the ratio of market capitalization to projected annual net income. A declining curve signals either undervaluation or rising risks. This is a key tool for determining the fundamental potential of the business.

Perusahaan pesaing

Pangali Forward P/E A|DGX - Rasio prakiraan rega marang bathi|Exact Sciences Corp - Prakiraan rega marang bathi|revvity.com (RVTY) - Rasio prakiraan rega marang bathi|Bio-Rad Laboratories, Inc. - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Anbio NNNN|Nordion (SHC) - Rega marang bathi mangsa ngarep|QDEL - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep OPKO Health Inc|CareDx (CDNA) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Maravai LifeSciences Holdings (MRVI)|FLGT: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Rasio prakiraan rega marang bathi|OraSure Corp - Pangali Forward P/E|Pangali forward rega marang bathi exagen.com (XGN)|MDXH: Pangali Forward P/E|LUCD - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi PRE|IMDX - Pangali forward rega marang bathi|Prakiraan rega marang bathi TRIB (Trinity Biotech plc)|Pangali Forward P/E prophaselabs.com (PRPH)|Pangali Forward P/E AIMD (Ainos Inc)|Pangali forward rega marang bathi Co-Diagnostics Inc|heartsciences.com - Pangali Forward P/E|Biomerica, Inc (BMRA) - Prakiraan rega marang bathi|CDIO: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep ONCO|Rega marang bathi mangsa ngarep Virax Biolabs|Bluejay Diagnostics, Inc. (BJDX) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Aspira Women's Health (AWH)|AXDX (Accelerate Diagnostics, Inc) - Pangali mangsa ngarep rega marang bathi|CENTOGENE, N.V. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENZ|Pangali mangsa ngarep rega marang bathi fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Rasio rega marang bathi mangsa ngarep|ME: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PMD